责任编辑：小浪快报 资料显示，荣科科技股份有限公司位于辽宁省沈阳市沈阳经济技术开发区开发大路7甲3号，成立日期 2005年11月18日，上市日期2012年2月16日，公司主营业务涉及智慧医疗、健康数据和智维云。主营业 务收入构成为：自主产品及服务73.25%，系统集成26.64%，其他(补充)0.12%。 截至9月30日，荣科科技股东户数5.40万，较上期减少10.80%；人均流通股11834股，较上期增加 12.10%。2025年1月-9月，荣科科技实现营业收入4.54亿元，同比减少4.49%；归母净利润-3169.01万 元，同比减少378.82%。 分红方面，荣科科技A股上市后累计派现9914.27万元。近三年，累计派现0.00元。 1月9日，荣科科技跌7.67%，成交额17.75亿元。两融数据显示，当日荣科科技获融资买入额1.80亿元， 融资偿还1.91亿元，融资净买入-1173.09万元。截至1月9日，荣科科技融资融券余额合计12.11亿元。 融资方面，荣科科技当日融资买入1.80亿元。当前融资余额12.11亿元，占流通市值的9.36%，融资余额 超过近一年60%分位水平，处于较高位。 融券方面，荣 ...

融资方面，荣科科技当日融资买入9612.38万元。当前融资余额14.38亿元，占流通市值的8.13%，融资 余额超过近一年90%分位水平，处于高位。 融券方面，荣科科技12月29日融券偿还3300.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量6900.00股，融券余额19.06万元，超过近一年90%分位水平，处于高位。 资料显示，荣科科技股份有限公司位于辽宁省沈阳市沈阳经济技术开发区开发大路7甲3号，成立日期 2005年11月18日，上市日期2012年2月16日，公司主营业务涉及智慧医疗、健康数据和智维云。主营业 务收入构成为：自主产品及服务73.25%，系统集成26.64%，其他(补充)0.12%。 12月29日，荣科科技跌4.00%，成交额9.62亿元。两融数据显示，当日荣科科技获融资买入额9612.38万 元，融资偿还9213.92万元，融资净买入398.46万元。截至12月29日，荣科科技融资融券余额合计14.38 亿元。 截至9月30日，荣科科技股东户数5.40万，较上期减少10.80%；人均流通股11834股，较上期增加 12.10%。2025年1月-9月，荣科科技 ...

Core Viewpoint - Rongke Technology's stock has shown significant growth this year, with a 43.73% increase, indicating strong market performance and investor interest [1][2]. Group 1: Stock Performance - As of November 11, Rongke Technology's stock price reached 29.25 CNY per share, with a market capitalization of 18.712 billion CNY [1]. - The stock has experienced a 4.06% increase over the past five trading days, a 21.57% increase over the past 20 days, and a 52.50% increase over the past 60 days [1]. - The company has appeared on the "龙虎榜" (a stock trading list) twice this year, with the most recent appearance on November 3 [1]. Group 2: Financial Performance - For the period from January to September 2025, Rongke Technology reported a revenue of 454 million CNY, a year-on-year decrease of 4.49% [2]. - The company recorded a net profit attributable to shareholders of -31.69 million CNY, representing a significant year-on-year decrease of 378.82% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Rongke Technology was 54,000, a decrease of 10.80% from the previous period [2]. - The average number of circulating shares per shareholder increased by 12.10% to 11,834 shares [2]. - The total cash dividends distributed by the company since its A-share listing amount to 99.1427 million CNY, with no dividends paid in the last three years [3].

Core Viewpoint - Rongke Technology's stock has shown volatility with a year-to-date increase of 14.94%, but a recent decline of 14.79% over the past 20 days, indicating mixed performance in the market [1][2]. Financial Performance - For the period from January to September 2025, Rongke Technology reported revenue of 454 million yuan, a year-on-year decrease of 4.49%, and a net profit attributable to shareholders of -31.69 million yuan, a significant decline of 378.82% [2]. - The company has cumulatively distributed 99.14 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of October 30, Rongke Technology's stock price was 23.39 yuan per share, with a trading volume of 283 million yuan and a turnover rate of 1.94%, resulting in a total market capitalization of 14.963 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 141 million yuan on August 13, accounting for 15.87% of total trading volume [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 10.80% to 54,000, while the average circulating shares per person increased by 12.10% to 11,834 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the seventh largest, holding 2.1668 million shares, an increase of 158,900 shares from the previous period [3]. Business Overview - Rongke Technology, established on November 18, 2005, and listed on February 16, 2012, operates in the fields of smart healthcare, health data, and intelligent cloud services, with main business revenue composition being 73.25% from self-developed products and services, 26.64% from system integration, and 0.12% from other sources [1].

Core Insights - Rongke Technology experienced a stock decline of 1.53% on October 20, with a trading volume of 475 million yuan [1] - The company reported a financing buy-in of 36.72 million yuan and a financing repayment of 61.74 million yuan on the same day, resulting in a net financing outflow of 25.02 million yuan [1] - As of October 20, the total margin balance for Rongke Technology was 1.282 billion yuan, representing 9.17% of its market capitalization, indicating a high level of financing [1] Financing Summary - On October 20, Rongke Technology had a financing buy-in of 36.72 million yuan, with a total financing balance of 1.282 billion yuan, which is above the 90th percentile of the past year [1] - The margin trading data showed no short selling activity on October 20, with a short selling balance of 0 yuan, indicating a lack of bearish sentiment [1] Company Performance - As of June 30, the number of shareholders for Rongke Technology was 60,600, a decrease of 6.30% from the previous period [2] - The company reported a revenue of 292 million yuan for the first half of 2025, a year-on-year decrease of 7.01%, and a net profit attributable to shareholders of -27.23 million yuan, a significant decline of 576.78% [2] - Since its A-share listing, Rongke Technology has distributed a total of 99.14 million yuan in dividends, with no dividends paid in the last three years [2] Shareholding Structure - As of June 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder of Rongke Technology, holding 2.0079 million shares, a decrease of 21,000 shares from the previous period [2]

Core Viewpoint - Rongke Technology's stock performance shows a slight increase, with significant financing activity indicating high investor interest despite a decline in revenue and profit [1][2]. Financing Activity - On October 15, Rongke Technology's stock rose by 0.71%, with a trading volume of 341 million yuan. The financing buy-in amounted to 35.46 million yuan, while financing repayment was 28.60 million yuan, resulting in a net financing buy of 6.85 million yuan [1]. - As of October 15, the total financing and securities lending balance for Rongke Technology reached 1.356 billion yuan, accounting for 8.75% of its market capitalization, which is above the 90th percentile of the past year [1]. - No shares were sold or repaid in the securities lending segment on October 15, with a balance of 0.00 yuan, indicating a high level of inactivity in this area [1]. Company Overview - Rongke Technology, established on November 18, 2005, and listed on February 16, 2012, is based in Shenyang, Liaoning Province. The company specializes in smart healthcare, health data, and intelligent cloud services [1]. - The revenue composition of Rongke Technology includes 73.25% from proprietary products and services, 26.64% from system integration, and 0.12% from other sources [1]. Financial Performance - For the first half of 2025, Rongke Technology reported a revenue of 292 million yuan, reflecting a year-on-year decrease of 7.01%. The net profit attributable to shareholders was -27.23 million yuan, a significant decline of 576.78% compared to the previous period [2]. - As of June 30, 2025, the number of shareholders decreased to 60,600, a reduction of 6.30%, while the average circulating shares per person increased by 6.76% to 10,556 shares [2]. - Since its A-share listing, Rongke Technology has distributed a total of 99.14 million yuan in dividends, with no dividends paid in the last three years [2].

Core Viewpoint - Rongke Technology's stock has shown significant volatility, with a year-to-date increase of 36.76% but a recent decline of 11.54% over the past five trading days [1] Financial Performance - As of June 30, 2025, Rongke Technology reported a revenue of 292 million yuan, a year-on-year decrease of 7.01%, and a net profit attributable to shareholders of -27.23 million yuan, a decline of 576.78% [2] - The company has cumulatively distributed 99.14 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] Stock Market Activity - On September 24, 2023, Rongke Technology's stock price reached 27.83 yuan per share, with a trading volume of 264 million yuan and a turnover rate of 1.52%, resulting in a total market capitalization of 17.804 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 141 million yuan on August 13, 2023 [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Rongke Technology was 60,600, a decrease of 6.30% from the previous period, with an average of 10,556 shares held per shareholder, an increase of 6.76% [2] - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 2.0079 million shares, a decrease of 21,000 shares from the previous period [3] Business Overview - Rongke Technology, established on November 18, 2005, and listed on February 16, 2012, operates in smart healthcare, health data, and intelligent cloud services [1] - The company's main business revenue composition is 73.25% from self-developed products and services, 26.64% from system integration, and 0.12% from other sources [1][2]